Pharmacological preconditioning with inhaled nitric oxide (NO): Organ-specific differences in the lifetime of blood and tissue NO metabolites
Keywords: Nitric oxide; Ischemia-reperfusion injury; NO metabolites; Cardioprotection; NO inhalation; Cardiac surgery; AAR; area at risk; AAR/LV; area at risk as a fraction of left ventricle; CAD; coronary artery disease; cGMP; cyclic guanosine monophosphate; iNO;